Intelligence · Patent portfolio
LEXICON PHARMACEUTICALS Patents
Full USPTO pharma patent portfolio for LEXICON PHARMACEUTICALS — grant dates, expiration, and drug cross-links.
- Patents
- 102
- Expiring ≤24m
- 4
Quick answer
LEXICON PHARMACEUTICALS has 102 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.
-
US 6524840
Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
expired -
US 6441153
Human carboxypeptidases and polynucleotides encoding the same
expired -
US 6441154
Human proteases and polynucleotides encoding the same
expired -
US 6403784
Human uncoupling proteins and polynucleotides encoding the same
expired -
US 6057104
Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation
expired -
US 6037125
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
expired
Frequently asked questions
How many patents does LEXICON PHARMACEUTICALS have?
102 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do LEXICON PHARMACEUTICALS patents expire?
4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources · Patent directory